1. Preface

   • Barry B. Bercu
   • Richard F. Walker

   EditorialNotes Pages: i - ii

2. Growth hormone secretagogues and hypothalamic networks

   • Marie-Thérèse Bluet-Pajot
   • Virginie Tolle
   • Claude Kordon

   OriginalPaper Pages: 1 - 8

3. Growth hormone secretagogue receptor family members and ligands

   • Roy G. Smith
   • Reid Leonard
   • Andrew Howard

   OriginalPaper Pages: 9 - 14

4. Central actions of the nonpeptide growth hormone secretagogue GHS-25

   • Alex R. T. Bailey
   • Louise Gilliver
   • Roy G. Smith

   OriginalPaper Pages: 15 - 19

5. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin

   • Gloria Shaffer Tannenbaum
   • Cyril Y. Bowers

   OriginalPaper Pages: 21 - 27

6. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland

   • Romano Deghenghi
   • Mauro Papotti
   • Vittorio Locatelli

   OriginalPaper Pages: 29 - 33

7. Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands

   • Emanuela Arvat
   • Laura Gianotti
   • Romano Deghenghi

   OriginalPaper Pages: 35 - 43

8. Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2

   • Johannes D. Veldhuis
   • William S. Evans
   • Stacey Anderson

   OriginalPaper Pages: 45 - 62

9. Effects of growth hormone and its secretagogues on bone

   • Johan Svensson
   • Sabrina Lall
   • John-Olov Jansson

   OriginalPaper Pages: 63 - 66

10. Synthetic growth hormone secretagogues control growth hormone secretion in the chicken at pituitary and hypothalamic levels

    • Kris L. Geris
    • Gerry J. Hickey
    • Veerle M. Darras

    OriginalPaper Pages: 67 - 72

11. The in vitro effect of leptin on growth hormone secretion from primary cultured ovine somatotrophs

    • Chen Chen
    • Sang-Gun Roh
    • Arieh Gertler

    OriginalPaper Pages: 73 - 78

12. Growth hormone/insulin-like growth factor1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1–44 NH₂ and in combination in older men and women with decreased growth hormone secretion

    • C. Y. Bowers
    • R. Granda-Ayala

    OriginalPaper Pages: 79 - 86

13. Biologic activities of growth hormone secretagogues in humans

    • Ezio Ghigo
    • Emanuela Arvat
    • Franco Camanni

    OriginalPaper Pages: 87 - 93

14. Growth hormone secretagogues as diagnostic tools in disease states

    • Roberto Baldelli
    • Xose L. Otero
    • Felipe F. Casanueva

    OriginalPaper Pages: 95 - 99

15. Presence of ghrelin in normal and adenomatous human pituitary

    • Márta Korbonits
    • Masayasu Kojima
    • Ashley B. Grossman

    OriginalPaper Pages: 101 - 104

16. Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy

    • Fabio Broglio
    • Andrea Benso
    • Ezio Ghigo

    OriginalPaper Pages: 105 - 108

17. Hexarelin, but not growth hormone, protects heart from damage induced in vitro by calcium deprivation replenishment

    • Antonio Torsello
    • Giuseppe Rossoni
    • Ferruccio Berti

    OriginalPaper Pages: 109 - 112

18. Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death

    • Nicoletta Filigheddu
    • Alberto Fubini
    • Andrea Graziani

    OriginalPaper Pages: 113 - 119

19. Preclinical pharmacology of CP-424,391, and orally active pyrazolinone-piperidine growth hormone secretagogue

    • Lydia C. Pan
    • Philip A. Carpino
    • David D. Thompson

    OriginalPaper Pages: 121 - 132

20. Do growth hormone-releasing peptides act as ghrelin secretagogues?

    • Ian Ahnfelt-Rønne
    • Jette Nowak
    • Uffe B. Olsen

    OriginalPaper Pages: 133 - 135

21. Recombinant human GHRH (1–44) NH₂

    • Mario R. Ehlers

    OriginalPaper Pages: 137 - 141